The percentage of deleterious BARD1 variants in the subset of patients with hereditary breast cancer (HBC) was 0.50%, 0.42% in hereditary ovarian cancer (HOC) cases and 0.33% in patients with HBOC (Table 1). The gene discussed is BARD1; the disease is Hereditary breast cancer.